Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Internal Model Harmonisation Approval

14 Sep 2021 14:07

RNS Number : 7533L
Phoenix Group Holdings PLC
14 September 2021
 

LEI: 2138001P49OLAEU33T68

 

Phoenix Group's Internal Model Harmonisation application is approved by the PRA

 

The Board of Phoenix Group Holdings plc ("the Group") is pleased to announce that the Prudential Regulation Authority ("PRA") has approved its application to harmonise its legacy Phoenix and Standard Life internal models.

 

This single, more sophisticated harmonised Internal Model will provide deeper insights into our risk profile which further strengthens the Group's risk management approach and decision making, as well as delivering significant capital synergies through diversification and improved risk modelling.

 

The harmonised Internal Model will go live effective 30 September 2021 and is currently estimated to increase the Group's Solvency II ("SII") Surplus by c.£0.4 billion. It is expected that c.£0.1 billion of the increased SII Surplus will then emerge as an acceleration of cash in 2022, after an appropriate period of operation.

 

The harmonised Internal Model also delivers a reduced capital strain for the Group's Bulk Purchase Annuity ("BPA") new business and unlocks a wider pipeline of future management actions including the execution of Part VIIs, the delivery of further enhancements to the Group's credit risk modelling capabilities and the foundation to bring ReAssure onto the new Internal Model in time. It will also support the Group in delivering future value accretive M&A.

 

-------------------------------------------------------------------------------------------------------------------------------------------------------

Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs, Phoenix Group

+44 (0)20 3735 0575

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 3735 0160

Media:

Douglas Campbell, Teneo

+44 (0)775 313 6628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 3735 0922

-------------------------------------------------------------------------------------------------------------------------------------------------------

Legal Disclaimers

This announcement in relation to Phoenix and its subsidiaries (the "Group") contains forward-looking statements about the Group's current plans, goals and expectations relating to future financial events, conditions, performance, results, strategy and/or objectives. Statements containing the words: 'believes', 'intends', 'will', 'expects', 'may', 'should', 'plans', 'aims', 'seeks', 'continues', 'targets' and 'anticipates' or other words of similar meaning are forward-looking. Such forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. As a result, such future events and the Group's actual future financial condition, performance and results may differ materially from the plans, goals and expectations set out in the forward-looking statements in this announcement. The Group undertakes no obligation to update any of the forward-looking statements contained within this announcement. References in this announcement to Solvency II Surplus should be read in conjunction with the relevant footnotes set out in the 2021 Half Year Results Announcement of 11 August 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGZGMLFDDGMZM
Date   Source Headline
7th Sep 20229:00 amRNSDirector/PDMR Shareholding
31st Aug 20225:00 pmRNSTotal Voting Rights
30th Aug 20224:30 pmRNSDirector/PDMR Shareholding
18th Aug 20225:00 pmRNSDirector/PDMR Shareholding
16th Aug 20224:30 pmRNSDirector/PDMR Shareholding
15th Aug 20227:00 amRNS2022 Half-Year Results
9th Aug 20224:30 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSPhoenix Group to acquire Sun Life UK
29th Jul 20224:00 pmRNSTotal Voting Rights
27th Jul 20223:45 pmRNSHolding(s) in Company
27th Jul 20223:31 pmRNSHolding(s) in Company
7th Jul 20224:45 pmRNSDirector/PDMR Shareholding
1st Jul 20222:00 pmRNSTotal Voting Rights
30th Jun 20224:30 pmRNSBlock Listing Return
29th Jun 20224:00 pmRNSBoard Changes Announcement
27th Jun 20223:15 pmRNSBlocklisting Application Announcement
9th Jun 20223:30 pmRNSDirector/PDMR Shareholding
31st May 20229:30 amRNSTotal Voting Rights
30th May 202211:00 amRNSBlock Listing Application
25th May 20223:00 pmRNSDirector/PDMR Shareholding
16th May 20224:30 pmRNSDirector/PDMR Shareholding
9th May 20223:00 pmRNSDirector/PDMR Shareholding
9th May 20222:15 pmRNSBoard Changes
5th May 20221:14 pmRNSResult of AGM
29th Apr 20225:00 pmRNSTotal Voting Rights
20th Apr 20226:30 pmRNSDirector/PDMR Shareholding
11th Apr 20226:00 pmRNSDirector/PDMR Shareholding
7th Apr 20224:45 pmRNSDirector/PDMR Shareholding
6th Apr 20225:00 pmRNSDirector/PDMR Shareholding
1st Apr 20225:00 pmRNSDirector/PDMR Shareholding
1st Apr 20222:00 pmRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSTotal Voting Rights
30th Mar 20222:00 pmRNSDirector/PDMR Shareholding
25th Mar 20225:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:00 pmRNSNotice of AGM
16th Mar 20226:27 pmRNSDirector/PDMR Shareholding
14th Mar 20227:00 amRNS2021 Annual Financial Report
9th Mar 202211:30 amRNSDirector/PDMR Shareholding
8th Mar 20225:00 pmRNSHolding(s) in Company
28th Feb 20224:30 pmRNSTotal Voting Rights
23rd Feb 20227:00 amRNSBoard Changes
11th Feb 20225:15 pmRNSDirector/PDMR Shareholding
11th Feb 202212:00 pmRNSDirector/PDMR Shareholding
9th Feb 20229:00 amRNSDirector/PDMR Shareholding
7th Feb 20222:30 pmRNSDirector/PDMR Shareholding
1st Feb 20222:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.